Quote | BioNTech SE (NYSE:BNTX)
Last: | $ |
---|---|
Change Percent: | -3.74% |
Open: | $30.00 |
Close: | $29.56 |
High: | $31.0999 |
Low: | $29.00 |
Volume: | 157,633 |
Last Trade Date Time: | 02/12/2020 04:44:12 pm |
News | BioNTech SE (NYSE:BNTX)
2024-04-22 14:20:23 ET Summary Hookipa Pharma is conducting a call on 04/25/24 to share lead asset HB-200's pivotal trial design. A Phase 2a clinical update is due in 2Q'24. The company's shares closed at $0.733, with a valuation of approximately $72.53. Positive data ...
MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and we...
Message Board Posts | BioNTech SE (NYSE:BNTX)
Subject | By | Source | When |
---|---|---|---|
$BNTX authorizes $500M share buyback for_remainder_of_2023: | DewDiligence | investorshub | 03/28/2023 4:16:08 PM |
Good article (eom). | DewDiligence | investorshub | 03/20/2023 9:32:31 PM |
https://www.fiercebiotech.com/biotech/bristol-myers-cmo-still-skeptical-about-ca | jondoeuk | investorshub | 03/20/2023 9:05:01 PM |
Data from the ongoing PhI/II in patients with | jondoeuk | investorshub | 03/20/2023 8:51:55 PM |
The company announces an exclusive license and collaboration | jondoeuk | investorshub | 03/20/2023 8:44:18 PM |
News, Short Squeeze, Breakout and More Instantly...
BioNTech SE Company Name:
BNTX Stock Symbol:
NYSE Market:
Moderna Inc. (NASDAQ:MRNA) is set to clash with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) i...
MAINZ, Germany, April 22, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and we...
2024-04-18 12:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...